Literature DB >> 7925868

Prognostic factors in malignant mesothelioma: where do we go from here?

J P Van Meerbeeck.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 7925868

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  3 in total

1.  Glutathione S-transferase expression in malignant mesothelioma and non-neoplastic mesothelium: an immunohistochemical study.

Authors:  K Segers; S Kumar-Singh; J Weyler; J Bogers; M Ramael; J Van Meerbeeck; E Van Marck
Journal:  J Cancer Res Clin Oncol       Date:  1996       Impact factor: 4.553

Review 2.  Prognostic markers in cancer: the evolution of evidence from single studies to meta-analysis, and beyond.

Authors:  R D Riley; W Sauerbrei; D G Altman
Journal:  Br J Cancer       Date:  2009-04-21       Impact factor: 7.640

3.  Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group.

Authors:  J van Meerbeeck; C Debruyne; N van Zandwijk; P E Postmus; M C Pennucci; F van Breukelen; D Galdermans; H Groen; P Pinson; M van Glabbeke; E van Marck; G Giaccone
Journal:  Br J Cancer       Date:  1996-09       Impact factor: 7.640
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.